Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     Prostate Cancer    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Global Hormonal Therapy (Marketed drugs) Market Research Report

  • Report Code: HO 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount
Hormonal Therapy (Marketed drugs) and its peer markets - Chemotherapy, Immunotherapy (Marketed drugs), Chromatography Instruments, Next Generation Sequencing (NGS), Chromatography, Clinical Trial Management Systems (CTMS), Healthcare IT outsourcing, Digital Pathology, Proteomics and 3 other markets - adds up to total Marketed Drugs (Prostate Cancer) market.

Hormonal Therapy (Marketed drugs) can be segmented by Submarkets, Geographies, Companies and Types. Submarkets of this market are Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems (CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Chromatography Instruments, Next Generation Sequencing (NGS) and Proteomics. Geographies of this market are Japan, India, Brazil, Russia, China, Turkey, Korea, Republic of (South Korea), Spain, Italy, USA, Canada, Germany, United Kingdom and France. Companies of this market are Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc., AstraZeneca, Astellas Pharma Inc., Tolmar Inc. and Ipsen Group. Types of this market are Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists, Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and Anti-Androgens.

 

Key Questions Answered

  • What are market estimates and forecasts; which of Hormonal Therapy (Marketed drugs) markets are doing well and which are not?
  • What is the competitive landscape; How companies like Sanofi-Aventis U.S., Abbott Laboratories and Dendreon Inc. doing in Hormonal Therapy (Marketed drugs)?
  •  

    What makes our report unique?

    • This reports provides most granular segmentation on Chromatography, E-Clinical Trial Solutions, Wireless Health and Clinical Trial Management Systems (CTMS).
    • This report provides market sizing and forecast for the Hormonal Therapy (Marketed drugs) market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
    • The report provides deep dive competitive landscape covering the top players such as Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc. and AstraZeneca.
    • The reports provides benchmarking insight on the top players Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc. and AstraZeneca.
    • The report provide competitive intelligence on Sanofi-Aventis U.S., Abbott Laboratories, Dendreon Inc. and AstraZeneca.
    •  

      Audience for this report

      • Global Hormonal Therapy (Marketed drugs) companies
      • Manufacturing Companies
      • Traders, distributors, and suppliers
      • Governmental and research organizations
      • Associations and industry bodies
      • Technology providers


1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Chromatography
4.2 E-Clinical Trial Solutions
4.3 Wireless Health
4.4 Clinical Trial Management Systems (CTMS)
4.5 Healthcare IT outsourcing
4.6 Immunoassay
4.7 Digital Pathology
4.8 Chromatography Instruments
4.9 Next Generation Sequencing (NGS)
4.10 Proteomics
5 By Types
5.1 Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists
5.2 Lutienizing Hormone-Releasing Hormone (LHRH) Analogs
5.3 Anti-Androgens
6 By Geographies
6.1 Japan
6.2 India
6.3 Brazil
6.4 Russia
6.5 China
6.6 Turkey
6.7 Korea, Republic of (South Korea)
6.8 Spain
6.9 Italy
6.10 USA
6.11 Canada
6.12 Germany
6.13 United Kingdom
6.14 France
7 By Companies
7.1 Sanofi-Aventis U.S.
7.2 Abbott Laboratories
7.3 Dendreon Inc.
7.4 AstraZeneca
7.5 Astellas Pharma Inc.
7.6 Tolmar Inc.
7.7 Ipsen Group

Please fill in the form below to receive a free copy of the Summary of this Report
















Global Hormonal Therapy (Marketed drugs) Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and
Upcoming
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs Lutienizing Hormone-Releasing Hormone (LHRH) Analogs
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and
Upcoming
Anti-Androgens Anti-Androgens
Anti-Androgens and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and
Upcoming
3 of 3 items
3 reports | Show
Connect With Us
US/CAN : +1-888-502-0539